NCT03351088

Brief Summary

Since its introduction, robot-assisted radical prostatectomy (RARP) have become the standard surgical approach for the treatment of prostate cancer in the United States and then in Europe. Continuous refinements of surgical technique has been described in order to maximise outcomes while minimizing morbidities. The management of DVC is a crucial steps during RARP. It could be done prior or after its transection thanks to haemostatic effects of the pneumoperitoneum. This topic has been already investigated by some authors. However, no high quality evidence is available to opt in favour of either of the two approaches. Findings about estimated blood loss, positive surgical margins and urinary recovery differ among these studies and only one is a randomized controlled trial in a laparoscopic setting with a limited number of patients. Therefore, our objective was to evaluate in a prospective randomised setting whether a delayed ligation of the dorsal vascular complex impacted on perioperative, functional and oncological outcomes as compared to preventive ligation during robot-assisted radical prostatectomy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
226

participants targeted

Target at P75+ for not_applicable prostate-cancer

Timeline
Completed

Started Aug 2016

Shorter than P25 for not_applicable prostate-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

November 19, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 22, 2017

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

November 22, 2017

Status Verified

November 1, 2017

Enrollment Period

1.3 years

First QC Date

November 19, 2017

Last Update Submit

November 19, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intraoperative estimated bool loss

    intraoperative

Secondary Outcomes (5)

  • Transfusion rate

    30 days from surgery

  • Overall positive surgical marigins

    intraoperative

  • Apical positive surgicals margins

    intraoperative

  • 1-month continence

    30 days from surgery

  • 1-month PSA

    30 days from surgery

Study Arms (2)

Preventive ligation

OTHER

Preventive ligation of DVC is done after the opening of endopelvic fascia and before bladder neck dissection. DVC is ligated at the level of the apex with a 8-fashion single stich (1-0 Monocryl® CT-1 stich) trying to preserve puboprostatic ligaments and the muscle fibres of the rabdosphincter. DVC is then dissected at the end of prostatectomy before the section of the urethra.

Procedure: DVC ligation

Delayed ligation

OTHER

Delayed ligation is done after the section of the urethra and once the prostatectomy is completed with a single stich (3-0 Monocryl® UR-6).

Procedure: DVC ligation

Interventions

DVC ligationPROCEDURE

Ligation of the dorsal vascular complex during robot-assisted radical prostatectomy

Delayed ligationPreventive ligation

Eligibility Criteria

Age18 Years - 80 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • male patients, aged 18-80 years
  • patients willing and able to provide written informed consent
  • voluntary partecipation
  • clinical indication to robot-assisted radical prostatectomy

You may not qualify if:

  • coagulation impairment at the time of surgery
  • salvage radical prostatectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Department of Urology, university Hospital Spedali Civili di Brescia

Brescia, 25123, Italy

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dirigente medico

Study Record Dates

First Submitted

November 19, 2017

First Posted

November 22, 2017

Study Start

August 1, 2016

Primary Completion

November 1, 2017

Study Completion

December 1, 2017

Last Updated

November 22, 2017

Record last verified: 2017-11

Locations